Article
A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics.
The Journal of molecular diagnostics : JMD - 1 May 2005
Jarvis Michael, Iyer Ramaswamy K, Williams Laurina O, Noll Walter W, Thomas Kirk, Telatar Milhan, Grody Wayne W
Abstract excerpt
The lack of readily available, patient-derived materials for molecular genetic testing of many heterozygous or rare disorders creates a major impediment for laboratory proficiency and quality control procedures. The paucity of clinically derived mutation-positive samples could be surmounted if it were possible to construct artificial samples containing mutations of interest that would sufficiently resemble...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
